Updates are available Correction dated 2023-09-25
Click to view Correction: https://doi.org/10.1007/s11154-023-09837-x
-
Authors
Giustina, Andrea http://orcid.org/0000-0001-6783-3398
di Filippo, Luigi http://orcid.org/0009-0002-6117-0081
Facciorusso, Antonio http://orcid.org/0000-0002-2107-2156
Adler, Robert A. http://orcid.org/0000-0002-2019-0417
Binkley, Neil http://orcid.org/0000-0002-9905-461X
Bollerslev, Jens http://orcid.org/0000-0002-0654-4610
Bouillon, Roger http://orcid.org/0000-0002-6446-3763
Casanueva, Felipe F. http://orcid.org/0000-0002-9052-8161
Cavestro, Giulia Martina http://orcid.org/0000-0003-1947-9368
Chakhtoura, Marlene http://orcid.org/0000-0003-0012-986X
Conte, Caterina http://orcid.org/0000-0001-7066-5292
Donini, Lorenzo M. http://orcid.org/0000-0003-4692-4754
Ebeling, Peter R. http://orcid.org/0000-0002-2921-3742
Fassio, Angelo http://orcid.org/0000-0001-9187-232X
Frara, Stefano http://orcid.org/0000-0002-1308-5598
Gagnon, Claudia http://orcid.org/0000-0001-9623-962X
Latella, Giovanni http://orcid.org/0000-0001-6341-5711
Marcocci, Claudio http://orcid.org/0000-0001-6568-8588
Mechanick, Jeffrey I. http://orcid.org/0000-0002-0657-588X
Minisola, Salvatore http://orcid.org/0000-0001-6525-0439
Rizzoli, René http://orcid.org/0000-0002-1537-422X
Santini, Ferruccio http://orcid.org/0000-0002-1706-0822
Shaker, Joseph L. http://orcid.org/0000-0002-6266-1029
Sempos, Christopher http://orcid.org/0000-0003-1324-3282
Ulivieri, Fabio Massimo http://orcid.org/0000-0003-1357-3425
Virtanen, Jyrki K. http://orcid.org/0000-0002-0648-999X
Napoli, Nicola http://orcid.org/0000-0002-3091-8205
Schafer, Anne L. http://orcid.org/0000-0002-4750-9125
Bilezikian, John P. http://orcid.org/0000-0002-1570-2617
-
Funding
Funding for this research was provided by:
Abiogen Pharma, Pisa
International Vitamin D Expert Association
- License Information
-
More Information
Article History
Accepted: 4 August 2023
First Online: 4 September 2023
Change Date: 25 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11154-023-09837-x
Declarations
:
: A.G.: consultant for Abiogen and Takeda and received research grant to Institution from Takeda; P.R.E.: Research grants from Amgen, Sanofi and Alexion. Honoraria from Amgen, Alexion and Gedeon Richter; A.F.: has received advisory board honoraria, consultancy fees and/or speaker fees from Boehringer Ingelheim, UCB pharma, Novartis, outside the submitted work; J.B has received advisory board honoraria from Ascendis Pharma; S.F.: received research grants to Institution from Abiogen Pharma; C.G.: received research grants from Takeda, Shire and Ascendis Pharma; C.M.: Advisory Board of Abiogen; J.I.M.: received honoraria for lectures from Abbott Nutrition and serve on Advisory Board of Twin Health; S.M.: served as speaker for Abiogen, Bruno Farmaceutici, Diasorin, Geopharma, Sandoz, UCB. He also served in advisory board of Abiogen, Eli Lilly, Kyowa Kirin, Novo Nordisk, UCB; R.R: consultant for Abiogen; F.S.: served as studies coordinator for NovoNordisk, EliLilly, Bruno farmaceutici, Pfizer, BioItalia; F.M.U.: Scientific Coordinator of the Bone Strain Index Project, Tecnologie Avanzate TA, S.r.l., Tourin, Italy. He has received speaker fee from Medimaps Group SA, Geneva, Switzerland; A.S.: research grant from Amgen; J.P.B. Consultant for Abiogen.
: L.D.F.; A.F.; R.A.; N.B; R.B.; F.F.C.; G.M.C.; M.C.; C.C.; L.M.D.; C.G.; G.L.; J.L.S.; C.S.; N.N.; J.K.V: no conflict of interest to declare.
